Patient Specific Considerations in Asthma Flashcards
Describe exercised induce bronchospasms(EIB)
airway narrowing as a result of physical activity
Cause of EIB
increase in the amount of cold, dry air entering the airways
Prevalence of EIB
-5-20% in general population
-90% of patients with SYMPTOMATIC asthma have EIB
True or false: lower prevalence of EIB among athletes
False, up to 30-70%
Characteristics of EIB
-poor asthma control
-can occur in pts with good asthma control
-can occur in pts without asthma
When does EIB occur?
-2-5 min AFTER exercise
-peak at 10 min
-resolves around 60 min
How do you treat EIB with poorly controlled asthma?
-5-20 minutes before exercise
-SABA: 2 inhalations
-budesonide-formoterol: 1 inhalations
-LTRA: 12 hour duration, take 2 hours before
Effect of asthma on pregnancy
-increase pregnancy risks
-affects 8-14% of pregnant women
-symptoms worse in second trimester
General rule for asthma in pregnancy
-1/3 get worse
-1/3 get better
-1/3 stable
Should you withhold asthma medications in pregnancy?
NO
-risks of asthma are worse than risk of meds
ICS therapy in pregnancy
-should be continued while attempting pregnancy and during pregnancy
do not attempt step down asthma therapy during pregnancy
-monitor ever 4-6 weeks
-asthma exacerbations should be managed aggressively
Preferred asthma meds in pregnancy
-ICS: Budesonide or fluticason
-LABA: Salmeterol or Formoterol
-Biologics: limited data, Omalizumab has best evidence
Non preferred asthma meds in pregnancy
Montelukast or Zarfirlukast
Oral Corticosteriods in pregnancy
-potential for side effects: pre-ecalmpsia, oral clefts, low birth weight
-Avoid as maintence therapy but burst is preferred
Addition considerations for asthma in pregnancy
–Use of ICS, SABA, LABA, theophylline, antihistamines, prednisone are OK with breastfeeding
-Influenza vaccine
-control environmental triggers
-STOP SMOKING
Aspirin Exacerbated Respiratory(AER) Disease
-asthma, nasal polyps, acute exacerbations following use of NSAID or aspirin
Clinical features of AER
-symptoms 30 min-3 hours following dose
-stuffy/waery nose, puffy eyes, wheezing, SOB,cough, chest tightness
Treatment of AER disease
-aggressive treatment of asthma and sinus disease
-Absolute avoidance of aspiring and COX-1 NSAIDs
-need to give patients a list of safe drugs
0nasal corticosteriods
-LTRA with mod-severe asthma
Persistent AERD
-biologics: dupilumab
-aspiring desensitization, followed by daily aspiring
Weakly selective COX-1 inhibitors
-Acetaminophen
-Salsalate
-Diflunisal
Highly selective COX2 inhibitors
-Celecoxib
Preferentially selective COX-2 inhibitors
Mexoxicam
ASA Desensitization
-uncontrolled respiratory symptoms despite optimal medical management
-Respiratory inflammatory disease
-multiple polyp surgeries
-requirement of asthma or treatment of other diseases